News Image

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

Provided By GlobeNewswire

Last update: May 14, 2025

BOSTON and LONDON, May 14, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today reported financial results and business highlights for the first quarter ended March 31, 2025.

Read more at globenewswire.com

CENTESSA PHARMACEUTICALS-ADR

NASDAQ:CNTA (7/25/2025, 8:00:00 PM)

After market: 15.41 0 (0%)

15.41

-0.07 (-0.45%)



Find more stocks in the Stock Screener

Follow ChartMill for more